Literature DB >> 24957412

Insights in Hodgkin Lymphoma angiogenesis.

Christian Marinaccio1, Beatrice Nico1, Eugenio Maiorano2, Giorgina Specchia3, Domenico Ribatti4.   

Abstract

Angiogenesis is a hallmark of tumor growth and progression in solid and hematological malignancies. Different cellular components of the tumor microenvironment such as macrophages, mast cells, circulating endothelial cells and angiogenic factors, including vascular endothelial growth factor and its receptors are involved in the maintenance of Hodgkin Lymphoma. In this review article, we highlight relevant literature focusing on the relationships between angiogenesis and Hodgkin Lymphoma as well as discussing anti-angiogenic treatments in this malignancy.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Anti-angiogenesis; Hodgkin Lymphoma; Tumor microenvironment

Mesh：

Substances：

Year:  2014        PMID： 24957412     DOI： 10.1016/j.leukres.2014.05.023

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  14 in total

1.  Preclinical activity of the repurposed drug auranofin in classical Hodgkin lymphoma.

Authors:  Marta Celegato; Cinzia Borghese; Naike Casagrande; Maurizio Mongiat; Xaver U Kahle; Alice Paulitti; Michele Spina; Alfonso Colombatti; Donatella Aldinucci
Journal:  Blood       Date:  2015-07-30       Impact factor: 22.113

Review 2.  Plants and their active compounds: natural molecules to target angiogenesis.

Authors:  Kai Lu; Madhavi Bhat; Sujit Basu
Journal:  Angiogenesis       Date:  2016-05-06       Impact factor: 9.596

Review 3.  The progress of angiogenic factors in the development of leukemias.

Authors:  Yang Han; Xidi Wang; Bingping Wang; Guosheng Jiang
Journal:  Intractable Rare Dis Res       Date:  2016-02

4.  Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma.

Authors:  F Linke; M Harenberg; M M Nietert; S Zaunig; F von Bonin; A Arlt; M Szczepanowski; H A Weich; S Lutz; C Dullin; P Janovská; M Krafčíková; L Trantírek; P Ovesná; W Klapper; T Beissbarth; F Alves; V Bryja; L Trümper; J Wilting; D Kube
Journal:  Leukemia       Date:  2016-08-18       Impact factor: 11.528

5.  Discovery of new therapeutic targets in ovarian cancer through identifying significantly non-mutated genes.

Authors:  Halema Al-Farsi; Iman Al-Azwani; Joel A Malek; Lotfi Chouchane; Arash Rafii; Najeeb M Halabi
Journal:  J Transl Med       Date:  2022-05-26       Impact factor: 8.440

6.  High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders.

Authors:  Antonella Caivano; Ilaria Laurenzana; Luciana De Luca; Francesco La Rocca; Vittorio Simeon; Stefania Trino; Fiorella D'Auria; Antonio Traficante; Maddalena Maietti; Tiziana Izzo; Giovanni D'Arena; Giovanna Mansueto; Giuseppe Pietrantuono; Luca Laurenti; Pellegrino Musto; Luigi Del Vecchio
Journal:  Tumour Biol       Date:  2015-07-09

7.  Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene.

Authors:  Melissa Rotunno; Mary L McMaster; Joseph Boland; Sara Bass; Xijun Zhang; Laurie Burdett; Belynda Hicks; Sarangan Ravichandran; Brian T Luke; Meredith Yeager; Laura Fontaine; Paula L Hyland; Alisa M Goldstein; Stephen J Chanock; Neil E Caporaso; Margaret A Tucker; Lynn R Goldin
Journal:  Haematologica       Date:  2016-06-13       Impact factor: 9.941

Review 8.  Tumor-Associated Mast Cells in Thyroid Cancer.

Authors:  Carla Visciano; Nella Prevete; Federica Liotti; Gianni Marone
Journal:  Int J Endocrinol       Date:  2015-08-26       Impact factor: 3.257

9.  Nucleoside 5'-O-monophosphorothioates as modulators of the P2Y14 receptor and mast cell degranulation.

Authors:  Edyta Gendaszewska-Darmach; Edyta Węgłowska; Aurelia Walczak-Drzewiecka; Kaja Karaś
Journal:  Oncotarget       Date:  2016-10-25

Review 10.  Role of Extracellular Vesicles in Hematological Malignancies.

Authors:  Stefania Raimondo; Chiara Corrado; Lavinia Raimondi; Giacomo De Leo; Riccardo Alessandro
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.